Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 3, 2013, Pages 325-329

  Baos, Elvira ^a   Candel, Francisco Javier ^a   Merino, Paloma ^a   Pena, Irene ^a   Picazo, Juan Jose ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cfr gene; G2576T; Linezolid resistance; Outbreak; S. aureus; Staphylococcus epidermidis

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; RIBOSOME PROTEIN; RIBOSOME PROTEIN L3; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CFR GENE; CONTROLLED STUDY; EPIDEMIC; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; INTENSIVE CARE UNIT; LINEZOLID RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; LINEZOLID RESISTANT STAPHYLOCOCCUS EPIDERMIS INFECTION; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CROSS INFECTION; DISEASE OUTBREAKS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; POINT MUTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84879143476     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.04.002     Document Type: Article

References (40)

1. Álvarez-Lerma F., Martínez M.P., Astigarraga P.O., et al. Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU. Rev Esp Quimioter 2012, 25:65-73.
2. Besier S., Ludwig A., Zander J., et al. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother 2008, 52:1570-1572.
3. Bonilla H., Huband M.D., Seidel J., et al. Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis 2010, 51:796-800.
4. Cercenado E. Update of antimicrobial resistance in Gram-positive microorganisms. Med Clin (Barc) 2010, 135(Suppl 3):10-15.
5. Cercenado E., Marin M., Insa R., et al. abstr. P979 2010.
6. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 21st informational supplement (M100-S20). Wayne, PA: CLSI; 2011.
7. de Almeida L.M., Lincopan N., de Araújo M.R., et al. Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil. J Antimicrob Chemother 2012, 67:768-769.
8. Endimiani A., Blackford M., Dasenbrook E.C., et al. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio. Antimicrob Agents Chemother 2011, 55:1684-1692.
9. Farrell D.J., Mendes R.E., Ross J.E., et al. Linezolid surveillance program results for 2008 (LEADER Program for 2008). Diagn Microbiol Infect Dis 2009, 65:392-403.
10. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
11. Gentry D.R., Rittenhouse S.F., McCloskey L., et al. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob Agents Chemother 2007, 51:2048-2052.
12. Gopegui E.R., Juan C., Zamorano L., et al. Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4')-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain. Antimicrob Agents Chemother 2012, 56:2139-2142.
13. http://hws.vhebron.net/envin-helics/.
14. Kehrenberg C., Schwarz S. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 2006, 50:1156-1163.
15. Kehrenberg C., Schwarz S., Jacobsen L., et al. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005, 57:1064-1073.
16. Kelly S., Collins J., Maguire M., et al. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother 2008, 61:901-907.
17. Kosowska-Shick K., Julian K.G., McGhee P.L., et al. Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital. Diagn Microbiol Infect Dis 2010, 68:34-39.
18. La Marre J.M., Locke J.B., Shawn K.J., et al. Low fitness cost of the multidrug resistance gene cfr. Antimicrob Agents Chemother 2011, 55:3714-3719.
19. Liakopoulos A., Spiliopoulou I., Damani A., et al. Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J Antimicrob Chemother 2010, 65:1070-1107.
20. Locke J.B., Hilgers M., Shaw K.J. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob Agents Chemother 2009, 53:5275-5278.
21. Locke J.B., Hilgers M., Shaw K.J. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 2009, 53:5265-5274.
22. Locke J.B., Morales G., Hilgers H., et al. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3. Antimicrob Agents Chemother 2010, 54:5352-5355.
23. Long K.S., Poehlsgaard J., Kehrenberg C., et al. The cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A antibiotics. Antimicrob Agents Chemother 2006, 50:2500-2505.
24. Meka V.G., Pillai S.K., Sakoulas G., et al. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23SrRNA gene and loss of a single copy of rRNA. J Infect Dis 2004, 190:311-317.
25. Mendes R.E., Deshpande L., Rodriguez-Noriega E., et al. First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization. J Clin Microbiol 2010, 48:3041-3043.
26. Mendes R.E., Deshpande L.M., Farrell D.J., et al. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother 2010, 65:2329-2335.
27. Morales G., Picazo J.J., Baos E., et al. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 2010, 50:821-825.
28. Mulanovich V.E., Huband M.D., McCurdy S.P., et al. Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization. J Antimicrob Chemother 2010, 65:2001-2004.
29. Olaechea P.M., Alvarez-Lerma F., Palomar M., et al. Grupo ENVIN-HELICS. Impact of primary and intravascular catheter-related bacteremia due to coagulase-negative staphylococci in critically ill patients. Med Intensiva 2011, 35:217-225.
30. Otto M. Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol 2012, 34:201-214.
31. Pillai S.K., Sakoulas G., Wennersten C., et al. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis 2002, 186:1603-1607.
32. Potoski B.A., Adams J., Clarke L., et al. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin Infect Dis 2006, 43:165-171.
33. Prystowsky J., Siddiqui F., Chosay J., et al. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001, 45:2154-2156.
34. Raad I., Hanna H.A., Alakech B., et al. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004, 140:18-25.
35. Rahkonen M., Luttinen S., Koskela M., et al. True bacteremia caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminats. Eur J Clin Microbiol Infect Dis 2012, 31:2639-2644.
36. Sánchez M., De la Torre M.A., Morales G., et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010, 303:2260-2264.
37. Seral C., Sáenz Y., Algarate S., et al. Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients. Int J Med Microbiol 2011, 301:354-358.
38. Toh S.M., Xiong L., Arias C.A., et al. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 2007, 64:1506-1514.
39. Treviño M., Martínez-Lamas L., Romero-Jung P.A., et al. Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit. Eur J Clin Microbiol Infect Dis 2009, 28:527-533.
40. Tsiodras S., Gold H.S., Sakoulas G., et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358:207-208.